 |
인쇄하기
취소
|
Chong Kun Dang announces launching of Generic Evista tablets
Chong Kun Dang Pharmaceutical Co. announced on October 23 that the company will market its generic version of Lilly's osteoporosis treatment (raloxifene hydrochloride) in the middle of next month.
“Our launching schedule was originally planned in July but delayed inevitably due to the import of raw materials that were not involved in the patent of crystal compound,” a company official said.
...
“Our launching schedule was originally planned in July but delayed inevitably due to the import of raw materials that were not involved in the patent of crystal compound,” a company official said.
...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.